16 May 2020
Nathalie Couturier (Gache team) will defend her PhD thesis on June 09 at 14h . Title: “Identification of new regulators of myonuclei positioning during skeletal
23 August 2022
XAB2 dynamics during DNA damage-dependent transcription inhibition Donnio LM, Cerutti E, Magnani C, Neuillet D, Mari PO, Giglia-Mari G. Elife, 2022 https://pubmed.ncbi.nlm.nih.gov/35880862/ Xeroderma Pigmentosum group A-binding
25 August 2022
https://doi.org/10.1002/humu.24445 Expanding the phenotypic variability of MORC2 gene mutations: From Charcot-Marie-Tooth disease to late-onset pure motor neuropathy Arnaud Jacquier1,2 | Shams Ribault1,3 | Michel Mendes4 |
30 November 2020
PhD defense of Jimmy Massenet (Team Chazaud) Harnessing epigenetics to improve Duchenne muscular dystrophy satellite cell function Thursday December 17th, 16:00 (videoconference)
11 January 2021
Hélène PUCCIO’s team received funding by FARA (Friedreich Ataxia Research Alliance) for the project entitled “Defining the therapeutic window and threshold for neuronal gene therapy in
15 May 2019
A new publication is available on bioRxiv! Skeletal muscle MACF1 maintains myonuclei and mitochondria localization through microtubules to control muscle functionalities Alireza Ghasemizadeh, Emilie Christin, Alexandre
12 January 2021
The team “Fundamental and pathophysiological mechanisms involved in ataxias” directed by Hélène Puccio has been awarded a FRM grant for the project: ” AtaxiaXplorer: Common pathways
